Insight

Latest California Healthline Stories

FDA Overlooked Red Flags In Drugmaker’s Testing of New Depression Medicine

In March, a chemical cousin of the anesthetic and club drug ketamine was approved for the treatment of patients with intractable depression. But critics say studies presented to the FDA provided at best modest evidence it worked and did not include information about the safety of the drug, Spravato, for long-term use.

Drug Users Armed With Naloxone Double As Medics On Streets Of San Francisco

The widespread availability of naloxone, which reverses overdoses, has radically changed the culture of opioid use on the streets, giving drug users a sense of security and inducing them to seek out the more powerful high of the synthetic opioid fentanyl.

How Measles Detectives Work To Contain An Outbreak

Across the nation, public health departments are redirecting scarce resources to try to control the spread of measles. Their success relies on shoe-leather detective work that is one of the great untold costs of the measles resurgence.

FAQ: How Does New Trump Fetal Tissue Policy Impact Medical Research?

The scientific use of tissue from aborted fetuses has frequently been a hot point of contention between anti-abortion forces and researchers. It heats up again as federal officials announced this week they were ending NIH research using the tissue.